A new review and meta-analysis, published in the journal PLOS Medicine, indicates that drug companies have increased disclosure of clinical trials of new antidepressants with negative outcomes, that is, trials that fail to show the drug is more effective than a placebo.

Read More

Oxford Health’s innovative ‘count me in’ pilot project is having a positive effect on research recruitment according to a letter published in the journal Evidence Based Mental Health.

Read More

In summer 2021 Oxford Health BRC took part in the In2Science programme. This is a scheme that gives young people from a range of backgrounds the opportunity to spend time with and learn from people working in research and to find out more about a career in science.

Read More

New research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People’s Advisory Group in the University of Oxford Department of Psychiatry and Oxford Health BRC and the…

Read More

In July 2021 researchers from the Oxford Health BRC hosted an Academic Industry Meeting Day (AIMday) in Experimental Medicine in Psychiatry. The day was an opportunity for researchers and industry…

Read More